Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recombinant Human Endostatin (Endostar) Combined With Concurrent Chemoradiotherapy for Advanced Non-small Cell Lung Cancer: A Multicenter, Randomized, Controlled Trial

NCT03588494 is registered in ClinicalTrials.gov with Affiliated Hospital of North Sichuan Medical College as lead sponsor.

NCT NCT03588494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03588494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recombinant Human Endostatin (Endostar) Combined With Concurrent Chemoradiotherapy for Advanced Non-small Cell Lung Cancer: A Multicenter, Randomized, Controlled Trial
Lead sponsor
Affiliated Hospital of North Sichuan Medical College
Phase
Phase 2/3
Overall status
Unknown status
Start date
August 1, 2018
Completion date
September 1, 2021
Enrollment
318 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

quality of life